Replacement therapy in pregnant women with von Willebrand disease during delivery: Factor levels and pharmacokinetics

Replacement therapy in pregnant women with von Willebrand disease during delivery: Factor levels and pharmacokinetics

Abstract Limited data are available on VWF activity (VWF:Act) and factor VIII (FVIII:C) levels during delivery after VWF/FVIII concentrate administration in women with von Willebrand disease (VWD). We aimed to evaluate treatment with a specific VWF/FVIII concentrate on factor levels in women with VW...

Full description

Saved in:
Bibliographic Details
Main Authors: Wala Al Arashi, Michael E. Cloesmeijer, Frank W. G. Leebeek, Johannes J. Duvekot, Marieke J. H. A. Kruip, Ron A. A. Mathôt, Marjon H. Cnossen, the OPTI‐CLOT/To WiN study group and SYMPHONY consortium
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:HemaSphere
Online Access:https://doi.org/10.1002/hem3.70061
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items